Impact of Removing Extended-Spectrum Beta Lactamase (ESBL) Staus Labeling from Culture Reports on Carapenem Prescribing for Non-Bacteremic Patients with Urinary Tract Infections: A Multi-hospital Assessment.

Publication Date

2023

Presented At:

IDWeek 2023. Boston, MA.

Content Type

Poster

This document is currently not available here.

Share

COinS